Chabiotech Co.,Ltd. (KOSDAQ:085660)
10,980
+660 (6.40%)
May 14, 2025, 2:40 PM KST
Chabiotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,045,049 | 953,951 | 844,583 | 727,476 | 664,717 | Upgrade
|
Other Revenue | -0 | -0 | -0 | - | - | Upgrade
|
Revenue | 1,045,049 | 953,951 | 844,583 | 727,476 | 664,717 | Upgrade
|
Revenue Growth (YoY) | 9.55% | 12.95% | 16.10% | 9.44% | 24.34% | Upgrade
|
Cost of Revenue | 775,225 | 682,936 | 643,558 | 513,978 | 478,143 | Upgrade
|
Gross Profit | 269,824 | 271,016 | 201,025 | 213,498 | 186,573 | Upgrade
|
Selling, General & Admin | 270,689 | 234,513 | 208,490 | 172,436 | 149,305 | Upgrade
|
Research & Development | 15,983 | 14,614 | 14,359 | 13,050 | 13,457 | Upgrade
|
Other Operating Expenses | 13,372 | 11,170 | 10,528 | 9,563 | 7,494 | Upgrade
|
Operating Expenses | 329,799 | 280,441 | 254,693 | 207,101 | 192,091 | Upgrade
|
Operating Income | -59,975 | -9,425 | -53,669 | 6,397 | -5,517 | Upgrade
|
Interest Expense | -37,165 | -29,101 | -20,868 | -14,534 | -14,919 | Upgrade
|
Interest & Investment Income | 10,442 | 12,923 | 6,593 | 5,177 | 3,887 | Upgrade
|
Earnings From Equity Investments | 14,314 | -281.48 | -13,489 | -246.17 | - | Upgrade
|
Currency Exchange Gain (Loss) | 17,805 | 1,529 | 5,442 | 6,934 | -8,443 | Upgrade
|
Other Non Operating Income (Expenses) | 28,751 | 23,761 | 11,713 | -14,485 | -3,408 | Upgrade
|
EBT Excluding Unusual Items | -25,829 | -594.36 | -64,278 | -10,756 | -28,400 | Upgrade
|
Gain (Loss) on Sale of Investments | 263.58 | 3,870 | -6,988 | 1,424 | 948.8 | Upgrade
|
Gain (Loss) on Sale of Assets | 21,904 | -26.53 | 138.34 | -657.11 | -2.34 | Upgrade
|
Asset Writedown | -1,132 | -453.62 | -329 | 101.17 | -1,529 | Upgrade
|
Other Unusual Items | -1,411 | 391.99 | 154.47 | -144.56 | -1,999 | Upgrade
|
Pretax Income | -6,204 | 3,188 | -71,302 | -10,033 | -30,981 | Upgrade
|
Income Tax Expense | 8,346 | 8,748 | -1,643 | 11,811 | 3,198 | Upgrade
|
Earnings From Continuing Operations | -14,550 | -5,560 | -69,659 | -21,844 | -34,179 | Upgrade
|
Net Income to Company | -14,550 | -5,560 | -69,659 | -21,844 | -34,179 | Upgrade
|
Minority Interest in Earnings | 6,496 | -2,871 | 22,116 | 7,875 | 15,521 | Upgrade
|
Net Income | -8,054 | -8,431 | -47,543 | -13,968 | -18,658 | Upgrade
|
Net Income to Common | -8,054 | -8,431 | -47,543 | -13,968 | -18,658 | Upgrade
|
Shares Outstanding (Basic) | 56 | 56 | 56 | 55 | 52 | Upgrade
|
Shares Outstanding (Diluted) | 59 | 57 | 56 | 55 | 52 | Upgrade
|
Shares Change (YoY) | 4.24% | 1.43% | 3.24% | 3.82% | -1.66% | Upgrade
|
EPS (Basic) | -143.89 | -149.80 | -844.95 | -256.29 | -355.41 | Upgrade
|
EPS (Diluted) | -143.89 | -149.80 | -845.00 | -256.29 | -356.00 | Upgrade
|
Free Cash Flow | -142,191 | -57,346 | -139,754 | -86,350 | -79,231 | Upgrade
|
Free Cash Flow Per Share | -2390.23 | -1004.83 | -2483.78 | -1584.36 | -1509.25 | Upgrade
|
Gross Margin | 25.82% | 28.41% | 23.80% | 29.35% | 28.07% | Upgrade
|
Operating Margin | -5.74% | -0.99% | -6.35% | 0.88% | -0.83% | Upgrade
|
Profit Margin | -0.77% | -0.88% | -5.63% | -1.92% | -2.81% | Upgrade
|
Free Cash Flow Margin | -13.61% | -6.01% | -16.55% | -11.87% | -11.92% | Upgrade
|
EBITDA | -14,966 | 28,374 | -21,149 | 34,260 | 19,924 | Upgrade
|
EBITDA Margin | -1.43% | 2.97% | -2.50% | 4.71% | 3.00% | Upgrade
|
D&A For EBITDA | 45,009 | 37,799 | 32,520 | 27,862 | 25,442 | Upgrade
|
EBIT | -59,975 | -9,425 | -53,669 | 6,397 | -5,517 | Upgrade
|
EBIT Margin | -5.74% | -0.99% | -6.35% | 0.88% | -0.83% | Upgrade
|
Effective Tax Rate | - | 274.41% | - | - | - | Upgrade
|
Advertising Expenses | 11,901 | 9,942 | 9,047 | 8,780 | 6,273 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.